Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate.
- 1 July 2001
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 145 (1), 137-140
- https://doi.org/10.1046/j.1365-2133.2001.04298.x
Abstract
Langerhans cell histiocytosis (LCH) can be a difficult therapeutic problem. We present a 40‐year‐old woman with a 4‐year history of LCH who was successfully treated with low‐dose methotrexate (20 mg weekly).This publication has 8 references indexed in Scilit:
- The confusing state of the histiocytosesBritish Journal of Dermatology, 2000
- Langerhans cell histiocytosis in the elderly: A report of three casesJournal of the American Academy of Dermatology, 1998
- Adult cutaneous Langerhans cell histiocytosisAustralasian Journal of Dermatology, 1998
- LANGERHANS CELL HISTIOCYTOSIS OF THE SKINHematology/Oncology Clinics of North America, 1998
- Histiocytose langerhansienne de l'adulte: localisations cutanéomuqueuses régressives après traitement par thalidomideLa Revue de Médecine Interne, 1998
- Langerhanszell-Histiozytose im AlterDie Dermatologie, 1998
- Complete remission of multicentric reticulohistiocytosis with combination therapy of steroid, cyclophosphamide, and low‐dose pulse methotrexate. Case report, review of the literature, and proposal for treatmentArthritis & Rheumatism, 1996
- Oral methotrexate and alternate‐day prednisone for low‐risk langerhans cell histiocytosisMedical and Pediatric Oncology, 1995